Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah King

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
JMIR Formative Research|September 2, 2024
Prescription Digital Therapeutics for Substance Use Disorder in Primary Care: Mixed Methods Evaluation of a Pilot Implementation StudyJessica Mogk, Abisola E Idu, Jennifer F Bobb, et al.
Implementation Research and Practice|December 16, 2024
Formative evaluation of the implementation of digital therapeutics for opioids and other substance use disorders in primary care (DIGITS trial)Lorella Palazzo, Caitlin N Dorsey, Jess Mogk, et al.
Journal of Alzheimer'S Disease : JAD|December 3, 2024
The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reductionDeborah E Barnes, Benjamin H Balderson, Lisa Shulman, et al.
Frontiers in Immunology|December 19, 2022
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assayNatalia Fernandez, Peter Hayes, Julia Makinde, et al.
PLOS Digital Health|January 8, 2026
Economic cost of strategic implementation approaches to increase uptake of digital therapeutics for substance use disorders in a large integrated health systemEdwin S Wong, Caitlin N Dorsey, Tara C Beatty, et al.
Environmental Health Perspectives|November 7, 2014
Diversity Outbred Mice Identify Population-Based Exposure Thresholds and Genetic Factors that Influence Benzene-Induced GenotoxicityJohn E French, Daniel M Gatti, Daniel L Morgan, et al.
Environmental Health Perspectives|June 30, 2018
Erratum: "Diversity Outbred Mice Identify Population-Based Exposure Thresholds and Genetic Factors that Influence Benzene-Induced Genotoxicity"John E French, Daniel M Gatti, Daniel L Morgan, et al.
Implementation Science : IS|February 2, 2023
Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial)Joseph E Glass, Caitlin N Dorsey, Tara Beatty, et al.
Frontiers in Immunology|March 29, 2021
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 InfectionJulia Makinde, Eunice W Nduati, Anna Freni-Sterrantino, et al.
Contemporary Clinical Trials|October 20, 2023
The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Brain Health Trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithmSascha Dublin, Mikael Anne Greenwood-Hickman, Leah Karliner, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
JMIR Formative Research|September 2, 2024
Prescription Digital Therapeutics for Substance Use Disorder in Primary Care: Mixed Methods Evaluation of a Pilot Implementation StudyJessica Mogk, Abisola E Idu, Jennifer F Bobb, et al.
Implementation Research and Practice|December 16, 2024
Formative evaluation of the implementation of digital therapeutics for opioids and other substance use disorders in primary care (DIGITS trial)Lorella Palazzo, Caitlin N Dorsey, Jess Mogk, et al.
Journal of Alzheimer'S Disease : JAD|December 3, 2024
The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reductionDeborah E Barnes, Benjamin H Balderson, Lisa Shulman, et al.
Frontiers in Immunology|December 19, 2022
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assayNatalia Fernandez, Peter Hayes, Julia Makinde, et al.
PLOS Digital Health|January 8, 2026
Economic cost of strategic implementation approaches to increase uptake of digital therapeutics for substance use disorders in a large integrated health systemEdwin S Wong, Caitlin N Dorsey, Tara C Beatty, et al.
Environmental Health Perspectives|November 7, 2014
Diversity Outbred Mice Identify Population-Based Exposure Thresholds and Genetic Factors that Influence Benzene-Induced GenotoxicityJohn E French, Daniel M Gatti, Daniel L Morgan, et al.
Environmental Health Perspectives|June 30, 2018
Erratum: "Diversity Outbred Mice Identify Population-Based Exposure Thresholds and Genetic Factors that Influence Benzene-Induced Genotoxicity"John E French, Daniel M Gatti, Daniel L Morgan, et al.
Implementation Science : IS|February 2, 2023
Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial)Joseph E Glass, Caitlin N Dorsey, Tara Beatty, et al.
Frontiers in Immunology|March 29, 2021
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 InfectionJulia Makinde, Eunice W Nduati, Anna Freni-Sterrantino, et al.
Contemporary Clinical Trials|October 20, 2023
The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Brain Health Trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithmSascha Dublin, Mikael Anne Greenwood-Hickman, Leah Karliner, et al.
Pageof 5